Insufficient efficacy of intravenous ketanserin in severe early-onset pre-eclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 128, Issue 1-2, 2006, Pages 199-203

  Hanff, Lidwien M ^a   Visser, Willy ^a   Roofthooft, Danielle W E ^a   Vermes, Andras ^a   Hop, Wim C J ^a   Steegers, Eric A P ^a   Vulto, Arnold G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antihypertensive treatment; Efficacy; Ketanserin; Pre eclampsia

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIHYDRALAZINE; KETANSERIN; KETANSERIN TARTRATE; MAGNESIUM SULFATE; METHYLDOPA; NICARDIPINE; NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; FATIGUE; FEMALE; GESTATIONAL AGE; HEART ARREST; HUMAN; HYPOTENSION; NOSE CONGESTION; ONSET AGE; PREECLAMPSIA; PRIORITY JOURNAL; QT PROLONGATION; RETROSPECTIVE STUDY; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE;

EID: 33748155684     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.11.032     Document Type: Article

References (14)

1. Visser W., and Wallenburg H.C. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 63 (1995) 147-154
2. Sibai B.M., Mercer B.M., Schiff E., and Friedman S.A. Aggressive versus expectant management of severe pre-eclampsia at 28-32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 171 (1994) 818-822
3. Visser W., and Wallenburg H.C.S. Temporising management of severe pre-eclampsia with and without the Hellp-syndrome. Br J Obstet Gynaec 102 (1995) 111-117
4. Bolte A.C., van Geijn H.P., and Dekker G.A. Pharmacological treatment of severe hypertension in pregnancy and the role of serotonine-2 receptor blockers. Eur J Obstet Gynecol Reprod Biol 95 (2001) 22-26
5. Spitz B., Witters K., Hanssens M., and Ketanserin. a 5HT2 serotonergic receptor antagonist, could be useful in the HELLP syndrome. Hypertens Pregnancy 12 (1993) 183-190
6. Bolte A.C., Eyck J.V., Kanhai H.H., Bruinse H.W., Geijn V.H.P., and Dekker G.A. Ketanserin versus dihydralazine in the management of severe early-onset pre-eclampsia: maternal outcome. Am J Obstet Gynecol 180 (1999) 371-377
7. Rossouw H.J., Howarth G., and Odendaal H.J. Ketanserin and hydralazine in hypertension in pregnancy-a randomised double-blind trial. S Afr Med J 85 (1995) 525-528
8. Duley L., and Henderson-Smart D.J. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev Issue 4 (2002)
9. Cameron H.A., Waller P.C., and Ramsay L.E. Prolongation of the QT interval by ketanserin. Postgrad Med J 64 (1988) 112-117
10. Van Schie D.L., de Jeu R.M., Steyn D.W., Odendaal H.J., and van Geijn H.P. The optimal dosage of ketanserin for patients with severe hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol 10 (2002) 161-166
11. Vatten L.J., and Skjaerven R. Is pre-eclampsia more than one disease?. BJOG 111 (2004) 298-302
12. Hanff L.M., Visser W., Hanff L.M., et al. Ketanserin in pre-eclamptic patients: transplacental transmission and disposition in neonates. BJOG 111 (2004) 863-868
13. Steyn D.W., Odendaal H.J., and Kirsten G.F. Mental development in children 6 years after in utero exposure to ketanserin - a follow-up study of a randomized controlled trial. Hypertens Pregnancy 21 Suppl.1 (2002) 131
14. Bolte A.C., van Eyck J., Gaffar S.F., van Geijn H.P., and Dekker G.A. Ketanserin for the treatment of preeclampsia. J Perinat Med 29 1 (2001) 14-22